IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q1 2017 Holdings

Filed 2017-05-12 | 13 holdings | $233.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$86.8K3,992,51737.2%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$71.3K1,573,02630.6%
Epizyme, Inc.(EPZMEUR)COM29428V104$26.5K1,543,11811.4%
Alder Biopharmaceuticals Inc.(ALDR1EUR)COM014339105$19.9K956,0418.5%
NanoString Technologies, Inc.(NSTGEUR)COM63009R109$9.8K492,5394.2%
Dermira, Inc.(DERMEUR)COM24983L104$6.3K185,2942.7%
Nexvet Biopharma public limited companyORD SHSG6503X109$3.4K877,1341.5%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$2.6K119,9121.1%
Orexigen Therapeutics, Inc.COM686164302$2.1K622,0130.9%
Zafgen, Inc.COM98885E103$2.1K449,4640.9%
Bellicum Pharmaceuticals, Inc.COM079481107$1.3K105,0000.6%
Acceleron Pharma Inc.(XLRN)COM00434H108$52719,9100.2%
Natera, Inc.(NTRA)COM632307104$45050,7370.2%